Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients

Inclusion Criteria

• • are male or female outpatients at least 18 years of age
• • provide written consent to the release of their data after being informed of the study
• • diagnosed with type 2 diabetes mellitus and are taking metformin, or a sulfonylurea or both
• • are reliable, and agree to keep all appointments for clinic visits, complete tests and procedures as may be required by the attending physician in the course of routine clinical care
• • are treated with exenatide according to the approved Product Insert, as prescribed by the investigator in the routine care of the patient